Influence of Control Group on Effect Size in Trials of Acupuncture for Chronic Pain: A Secondary Analysis of an Individual Patient Data Meta-Analysis

MacPherson et al. · PLOS ONE · 2014

📊Individual patient data meta-analysis👥n=19,827🔍29 trials analyzed

Evidence Level

STRONG
85/ 100
Quality
5/5
Sample
5/5
Replication
4/5
🎯

OBJECTIVE

Analyze how different types of controls (sham and non-sham) influence the effect size of acupuncture in chronic pain

👥

WHO

19,827 patients with chronic pain (low back, neck, shoulder, osteoarthritis, headache)

⏱️

DURATION

Data from 29 trials conducted between 1999-2008

📍

POINTS

Analysis of different techniques: penetrating needles, non-penetrating needles, and no-needle controls

🔬 Study Design

19827participants
randomization

Sham controls

n=5230

20 trials with simulated acupuncture

Non-sham controls

n=14597

18 trials with usual care/protocol-guided care

⏱️ Duration: Meta-analysis of trials from 1999-2008

📊 Results in numbers

0

Acupuncture superiority vs. penetrating needles

0

Superiority vs. non-penetrating needles

0

Difference between penetrating vs. non-penetrating

0

Acupuncture vs. routine care

0

Acupuncture vs. protocol-guided care

📊 Outcome Comparison

Effect Size (standard deviation)

Penetrating Needles
0.17
Non-Penetrating Needles
0.43
No Needles
0.38
💬 What does this mean for you?

This study shows that acupuncture is effective for chronic pain regardless of the type of control used. However, it found that 'fake' needles that penetrate the skin have some therapeutic effect of their own, suggesting that even superficial acupuncture at incorrect points may have benefits.

📝

Article summary

Plain-language narrative summary

This study represents a fundamental secondary analysis of the Acupuncture Trialists' Collaboration individual patient data meta-analysis, investigating how different types of control groups influence the effect size observed in acupuncture trials for chronic pain. The researchers analyzed data from 29 high-quality randomized controlled trials, including 19,827 patients with chronic painful conditions such as low back pain, neck pain, shoulder pain, osteoarthritis, and headache. The study was motivated by the need to better understand variations in acupuncture trial results, which can be influenced by the choice of control group. The methodology involved detailed categorization of the types of controls used in the original studies.

For sham controls (simulated acupuncture), the researchers classified whether needles or noninvasive methods were used, whether the needles penetrated the skin, and whether they were applied at true acupuncture points. For non-sham controls, they distinguished between 'routine care' (unspecified treatment as needed) and 'protocol-guided care' (standardized treatment specified in the study protocol). The results revealed that acupuncture was significantly superior to all types of controls. However, important differences in effect size were found depending on the type of control used.

In trials with sham controls, acupuncture showed less superiority when compared with penetrating needles (effect size: 0.17) than when compared with non-penetrating needles (0.43) or no-needle methods (0.38). The difference between penetrating and non-penetrating needles was statistically significant (-0.45; p = 0.007). For non-sham controls, although the difference did not reach statistical significance, there was a trend toward a greater acupuncture effect versus routine care (0.55) compared with protocol-guided care (0.29). These findings have important implications for the interpretation of clinical trials and for the design of future studies.

The results suggest that penetrating needles, even when inserted superficially at non-acupuncture points, possess physiologic activity of their own, calling into question their suitability as a true placebo control. This is consistent with theories about acupuncture mechanisms, which may include stimulation of nerve endings and release of neurotransmitters even with superficial insertion. The study also demonstrates that the intensity of treatment in the control group influences the observed effect size, with direct implications for sample size calculations in future trials. Limitations include the limited number of trials using some specific control types and heterogeneity in the practical implementation of sham controls.

In addition, incomplete understanding of acupuncture mechanisms limits definitive conclusions about which controls can be considered true placebos. For researchers, this study recommends avoiding penetrating needles as a sham control when the goal is to control for nonspecific effects, favoring non-penetrating needles or no-needle methods. For clinicians and patients, the results reinforce the efficacy of acupuncture for chronic pain regardless of the type of control, but suggest that the benefits may be even greater than previous estimates indicated.

Strengths

  • 1Largest individual patient database in acupuncture
  • 2Systematic analysis of different control types
  • 3Rigorous methodology with well-defined inclusion criteria
  • 4Comprehensive sensitivity analyses
⚠️

Limitations

  • 1Few studies with some specific control types
  • 2Limited understanding of acupuncture mechanisms
  • 3Heterogeneity in control implementation
  • 4Subjective categorization of some control types
Dr. Marcus Yu Bin Pai

Expert Commentary

Dr. Marcus Yu Bin Pai

MD, PhD · Pain Medicine · Physical Medicine and Rehabilitation · Medical Acupuncture

Clinical Relevance

Working with chronic musculoskeletal pain requires the clinician to position acupuncture within an evidence-based practice without methodologic naivete. This work by MacPherson and colleagues, by stratifying 29 trials and nearly 20,000 patients by type of control group, offers a direct conceptual tool for that positioning. The effect size of 0.55 for acupuncture versus routine care is clinically meaningful and fits the populations we see day to day — chronic low back pain, neck pain, knee osteoarthritis, chronic tension-type headache — where the pharmacologic armamentarium frequently exhausts its effectiveness or causes intolerable adverse effects. The analysis also allows the physician to explain to the patient, on solid grounds, that the benefits of acupuncture transcend expectation and care context, without resorting to mechanistic arguments that remain incomplete.

Notable Findings

The most provocative finding in this analysis is the statistically significant difference of 0.45 between penetrating and non-penetrating needles as sham controls. This unravels a widely accepted methodologic premise: needles inserted superficially outside acupuncture points are not inert placebo. They stimulate cutaneous mechanoreceptors and nociceptors, activating segmental and suprasegmental circuits involved in pain modulation — entirely consistent with what we know about the neurophysiology of needling. Consequently, trials that used this kind of sham systematically underestimated the true effect of acupuncture, and the effect sizes reported in those studies need to be reread with that adjustment in mind. The 0.17 effect size against penetrating needles versus 0.43 against non-penetrating needles is not statistical noise — it is a physiologic signal mischaracterized as a control.

From My Experience

In my practice in the musculoskeletal pain clinic, this discussion of what constitutes a true placebo in acupuncture stopped being academic a long time ago. I typically see a perceptible clinical response between the third and fifth session in most patients with moderate chronic low back or neck pain, and I run the acute phase with eight to twelve sessions before deciding on monthly maintenance. The profile that responds best is the patient with moderate central sensitization, without major somatization or evident secondary gain. I systematically combine acupuncture with supervised exercise and, when there is a dominant myofascial component, dry needling of trigger points in alternating sessions. The data in this article reinforce something I have observed empirically: patients in control groups of trials using penetrating needles are not receiving placebo — they are receiving an attenuated form of neuromodulation. That completely changes how I interpret any meta-analysis using that design.

PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture.

Full original article

Read the full scientific study

PLOS ONE · 2014

DOI: 10.1371/journal.pone.0093739

Access original article

Scientific Review

Marcus Yu Bin Pai, MD, PhD

Marcus Yu Bin Pai, MD, PhD

CRM-SP: 158074 | RQE: 65523 · 65524 · 655241

PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture. Scientific review and curation of every entry in this library.

Learn more about the author →
⚕️

Medical disclaimer: This content is for educational purposes only and does not replace consultation, diagnosis, or treatment by a qualified professional. Some information may be assisted by artificial intelligence and is subject to inaccuracies. Always consult a physician.

Content reviewed by the medical team at CEIMEC — Integrated Centre for Chinese Medicine Studies, a reference in Medical Acupuncture for over 30 years.